Gradient Investments’s GW Pharmaceuticals Plc American Depositary Shares GWPH Stock Holding History

Gradient Investments’s Portfolio GWPH Stock Details GWPH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q2	–	Sell	-65	Closed	-$14K	–	1306
2021 Q1	$14K	Buy	65 +50	+333%	+$9.4K	﹤0.01%	700
2020 Q4	$1K	Hold	15	–	–	﹤0.01%	1114
2020 Q3	$1K	Hold	15	–	–	﹤0.01%	1118
2020 Q2	$2K	Hold	15	–	–	﹤0.01%	936
2020 Q1	$1K	Hold	15	–	–	﹤0.01%	1068
2019 Q4	$2K	Hold	15	–	–	﹤0.01%	975
2019 Q3	$2K	Hold	15	–	–	﹤0.01%	957
2019 Q2	$3K	Buy	+15	New	+$2.59K	﹤0.01%	853
2018 Q4	–	Sell	-21	Closed	-$4K	–	1143
2018 Q3	$4K	Hold	21	–	–	﹤0.01%	783
2018 Q2	$3K	Hold	21	–	–	﹤0.01%	795
2018 Q1	$2K	Hold	21	–	–	﹤0.01%	857
2017 Q4	$3K	Buy	+21	New	+$2.47K	﹤0.01%	780
2017 Q3	–	Sell	-21	Closed	-$2K	–	784
2017 Q2	$2K	Buy	+21	New	+$2.26K	﹤0.01%	704

Other funds holding GWPH

HDIM

Hanson & Doremus Investment Management Burlington, Vermont $869M AUM 23.62% 1-Year Est. Return

Gradient Investments's GWPH Position: Q2 2021 in Review

Gradient Investments sold out of GW Pharmaceuticals Plc American Depositary Shares (GWPH) in Q2 2021, closing a stake of 65 shares — an estimated $14K sold.

Gradient Investments first reported a position in GWPH in Q2 2017 and held it in 13 quarters. The position peaked at $14K in Q1 2021. 1 fund tracked by Wall St. Rank holds GWPH as of Q2 2021.

Gradient Investments reported no remaining GW Pharmaceuticals Plc American Depositary Shares position as of Q2 2021 after selling out during the quarter.
Gradient Investments sold 65 GW Pharmaceuticals Plc American Depositary Shares shares in Q2 2021, an estimated $14K.
Gradient Investments first reported a position in GW Pharmaceuticals Plc American Depositary Shares in Q2 2017 and held it in 13 quarters.
Gradient Investments's GW Pharmaceuticals Plc American Depositary Shares position peaked at $14K in Q1 2021.
1 fund tracked by Wall St. Rank held GW Pharmaceuticals Plc American Depositary Shares as of Q2 2021.

Based on Gradient Investments's 13F filing for Q2 2021, filed 12 Jul 2021.